Sabra Healthcare REIT, Inc. $SBRA Shares Acquired by Nomura Asset Management Co. Ltd.

Nomura Asset Management Co. Ltd. lifted its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 8.2% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 376,600 shares of the real estate investment trust’s stock after buying an additional 28,400 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Sabra Healthcare REIT were worth $7,133,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Rothschild Investment LLC boosted its stake in shares of Sabra Healthcare REIT by 164.6% during the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 889 shares during the period. Founders Capital Management acquired a new stake in Sabra Healthcare REIT in the third quarter valued at about $28,000. Strengthening Families & Communities LLC acquired a new stake in Sabra Healthcare REIT in the fourth quarter valued at about $29,000. Danske Bank A S acquired a new stake in Sabra Healthcare REIT in the third quarter valued at about $30,000. Finally, Larson Financial Group LLC lifted its position in Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 553 shares during the period. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Down 2.6%

Shares of Sabra Healthcare REIT stock opened at $18.09 on Thursday. Sabra Healthcare REIT, Inc. has a 12-month low of $17.17 and a 12-month high of $21.28. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. The stock has a market cap of $4.56 billion, a PE ratio of 28.71, a price-to-earnings-growth ratio of 1.39 and a beta of 0.64. The company has a 50-day moving average of $20.22 and a two-hundred day moving average of $19.70.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. During the same period last year, the company posted $0.37 earnings per share. The firm’s quarterly revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.51 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.6%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 190.48%.

Analyst Ratings Changes

A number of brokerages recently commented on SBRA. Truist Financial raised their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research report on Friday, March 13th. Citigroup raised their price objective on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, February 18th. Wells Fargo & Company raised their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research report on Monday. Cantor Fitzgerald raised their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. Finally, Citizens Jmp raised their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 18th. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, Sabra Healthcare REIT has an average rating of “Moderate Buy” and a consensus price target of $22.40.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.